HomeCancerLeukemia

Leukemia

Leukemia

Famend Leukemia Researcher and Clinician Joins NYU Langone Well being’s Perlmutter Most cancers Middle as New Chief Scientific Officer

Editor -
NEW YORK, July 25, 2024 /PRNewswire/ -- NYU Langone Well being's Perlmutter Most cancers Middle has named Jonathan M. Gerber, MD, as its...
Leukemia

Pharmacotyping gives a precision drugs blueprint for acute lymphoblastic leukemia therapy

Editor -
“In comparison with conventional most cancers genomics analysis, our work begins with defining the drug-response phenotype of every affected...
Leukemia

Achieve-of-function mutation reveals new goal in pediatric acute myeloid leukemia

Editor -
The researchers had beforehand categorized pediatric AML into 23 molecular subtypes, together with 12 unrecognized by the World Well...
Leukemia

Distinct molecular profiles result in a greater understanding of acute leukemia

Editor -
The complicated and numerous nature of the genetic alterations driving acute leukemia could make these ailments difficult to deal...
Leukemia

Mutation in Bruton Tyrosine Kinase (BTK) A428D confers resistance To BTK-degrader remedy in power lymphocytic leukemia

Editor -
The enzyme Bruton tyrosine kinase (BTK) is concerned in B-cell signaling that promotes the migration, proliferation, and survival of neoplastic B-cells of sufferers...
1...678...80Page 7 of 80

Hot Topics

Load more

Quick Links

Must Read

Popular Articles

© 2024 Cancer Care Portal. All rights reserved.